Products
Online Inquiry
SCR-1481B1
Cat. No.:
OB0225WX-1967
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
SCR-1481B1 is a dual-action kinase inhibitor possessing significant inhibitory activity against both VEGFR and Met-activated signaling pathways.
Synonym:
c-Met inhibitor 2; 1174161-86-4; c-Met inhibitor 2; 2-amino-2-(hydroxymethyl)propane-1,3-diol (3-((4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)carbamoyl)-5-(4-fluorophenyl)-4-oxopyridin-1(4H)-yl)methyl phosphate; [3-[[4-(2-amino-3-chloropyridin-4-yl)oxy-3-fluorophenyl]carbamoyl]-5-(4-fluorophenyl)-4-oxopyridin-1-yl]methyl dihydrogen phosphate;2-amino-2-(hydroxymethyl)propane-1,3-diol
CAS No.:
1174161-86-4
Compound CID:
119081412
Formula:
C32H40ClF2N6O13P
Formula Weight:
821.12
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SCR-1481B1 is employed in chemical biology research as a specialized molecular tool to study the specific inhibition of targeted kinase pathways and their biological consequences in cellular assays.
Library Information
Target:
VEGFR; c-Met/HGFR
Receptor:
c-Met/HGFR; VEGFR; VEGFR1
Pathways:
Tyrosine kinase/adaptors; Angiogenesis
Plate Number:
AOCL-26
Plate Location:
b9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
31 mg/mL; 44.29 mM
